Medical Devices Today

The Future of Laparoscopy: Single Incision, NOTES and Robots

Article preview from Start Up - July, 2010

The skill sets of laparoscopy, endoscopy, robotics and even interventional cardiology are all converging to create least invasive surgeries that take laparoscopy as a point of departure but change how surgeons access the abdominal cavity. Start-ups are innovating to supply the new surgical instruments.

Medtronic buys Invatec for $350mm, plus earn-outs

Deal summary reprinted from Strategic Transactions - January, 2010

Medtronic has agreed to acquire closely held European interventional cardio device developer Invatec and its affiliates Fogazzi (provides Invatec with polymer technology) and Krauth Cardiovascular (Invatec's German distributor) for $350mm. It will also provide earn-outs of up to $150mm if certain milestones are reached.

Medtronic to Acquire Invatec For $350 Million

Acquisition Will Expand Product Offering and Pipeline for Cardiovascular Interventions

Press release reprinted from www.medtronic.com

Editor's Note: Invatec was featured in the October 2009 issue of IN VIVO. Purchase "Invatec: Translating Global Success in Vascular Devices to the US Market" to learn more about Invatec's track record, management team and strategic vision for the U.S. vascular device and interventional cradiology markets.

MINNEAPOLIS – Jan. 25, 2010 – Moving to expand its impact on peripheral vascular disease, Medtronic, Inc. (NYSE: MDT), announced today that it has signed a definitive agreement to acquire Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease, and two affiliated companies: Fogazzi, which provides polymer technology to Invatec; and Krauth Cardiovascular, which distributes Invatec products in Germany. The agreement calls for Medtronic to make an initial payment of $350 million to Invatec and additional payments of up to $150 million for Invatec’s achievement of specific milestones.

Medtech Deals—Recent Financing Trends

By Peggy Steif Abram, Angie D. Snavely and Jonathan R. Zimmerman - Faegre & Benson
The medtech industry was not immune from the economic woes of 2008 and 2009, and financing opportunities were greatly reduced. In 2008, overall financing for medtech companies in the U.S. dropped 53 percent. Read more...

CircuLite brings in $32.5mm so far with Series C round

Deal summary reprinted from Strategic Transactions - December, 2009

CircuLite (heart assist device) has raised $10.5mm of a proposed $33mm Series C venture round. The company has secured $23.5mm in commitments from insiders and new investors. Forbion Capital Partners led the financing and was joined by current backers Credit Agricole Private Equity, Foundation Medical Partners, and Oxford Bioscience Partners. Read more...

CeQur raises CHF31.7mm in Series A financing

Deal summary reprinted from Strategic Transactions - December, 2009

CeQur SA (insulin delivery systems for managing Type II diabetes) has closed its Series A round, raising a total of CHF31.7mm ($29.6mm) from BMC Ventures, Endeavour Vision, Schroder & Co. Bank, and Venture Incubator. Reas more...

Roche pens companion test deal with Psynova, RBM

Deal summary reprinted from Strategic Transactions - December 2009

Rules-Based Medicine (RBM; multiplexed immunoassay technologies) and its neuropsychiatric biomarkers subsidiary Psynova Neurotech have signed an exclusive agreement with Roche to develop companion diagnostic immunoassays for one the of Big Pharma's neurology drug candidates. Read more...

Apnex Medical raises $30mm in first venture round

Deal summary reprinted from Strategic Transactions - December 2009

Device start-up Apnex Medical grossed $16.1mm in its Series A financing, which included Domain Associates, New Enterprise Associates, Polaris Venture Partners, and individual investor and company chairman Michael Berman. Members from each VC firm join Apnex's board. Read more...

SpinalMotion gets $27.4mm via Series D

Deal summary reprinted from Strategic Transactions - November 2009

SpinalMotion (developing cervical implants for degenerative disc disease) raised $27.4mm in its Series D financing round, which included new investor DAFNA Capital Management. Concurrently, the company announced that it filed the PMA for its Kineflex lumbar artificial disc.

Sonova pays $489mm cash for Advanced Bionics

Deal summary reprinted from Strategic Transactions - November 2009

Sonova Holding AG has acquired private company Advanced Bionics for $463.5mm up front plus $25.5mm to be held in escrow, or a total of $489mm, paying just over four times what the fellow hearing systems maker achieved in revenues last year. Read more...